Scholars Central

PerspectivePublished 21 Jul 2016

How transcatheter aortic valve implantation can revive balloon aortic valvuloplasty

Authors: AS Petronio, C Giannini, F De Caro & M De Carlo

Interventional Cardiology

Volume 6 · Issue 3 · Pages 279–288

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Percutaneous balloon aortic valvuloplasty (PBAV) was first described as a new therapeutic option in patients with aortic stenosis who could not undergo surgical aortic valve replacement (SAVR) in a pediatric population in 1984 by Lababidi, and in elderly adults in 1986 by Cribier et al. This treatment was found to be an interesting option in high-risk patients with hemodynamic instability, showing good procedural and short-term results, yielding improvement of symptoms, amelioration of global clinical status and improvement of echocardiographic parameters.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Interventional Cardiology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInterventional Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “AS Petronio”
  • BylineArticles whose byline prints “C Giannini”